How do citizens imagine the future of European healthcare? What can Europe learn from COVID-19 drug and vaccine development? How can Europe ensure that the most advanced and effective medicines are not just available to the wealthiest in society, but that they can benefit the public more generally?
Can technological innovation help drive costs down (and even facilitate more personalised medicine for individual patients)? How can that impulse be balanced against the costs of research and development? Should EU medicine supply chains be shorter and more sustainable?
These questions, plus many more, will be addressed in the series of online panel debates below.
Debating Europe is inviting policymakers and experts to respond to YOUR questions on the COVID-19 pandemic.
Join the debate!